Key Details
Price
$16.80Annual ROE
4.44%Beta
0.97Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
N/ARecent annual earnings:
N/ANext ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
15 Nov '24 UBS
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Telix Pharmaceuticals Limited doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Illuccix® Receives European Approval
TLX
globenewswire.com16 January 2025
On January 17, 2025, Telix Pharmaceuticals Limited, based in Melbourne, Australia, and Liège, Belgium, announced that it has received a favorable decision regarding its Marketing Authorization Application (MAA) for the prostate cancer PET1 imaging agent, Illuccix®. This agent is a kit used to prepare gallium-68 gozetotide injection and was submitted in Europe through a decentralized procedure (DCP).
FAQ
- What is the primary business of Telix Pharmaceuticals Limited?
- What is the ticker symbol for Telix Pharmaceuticals Limited?
- Does Telix Pharmaceuticals Limited pay dividends?
- What sector is Telix Pharmaceuticals Limited in?
- What industry is Telix Pharmaceuticals Limited in?
- What country is Telix Pharmaceuticals Limited based in?
- When did Telix Pharmaceuticals Limited go public?
- Is Telix Pharmaceuticals Limited in the S&P 500?
- Is Telix Pharmaceuticals Limited in the NASDAQ 100?
- Is Telix Pharmaceuticals Limited in the Dow Jones?
- When does Telix Pharmaceuticals Limited report earnings?
What is the primary business of Telix Pharmaceuticals Limited?
TLX Corporation is a company that specializes in providing technology solutions and services, focusing on enhancing communication and connectivity for businesses and individuals.
What is the ticker symbol for Telix Pharmaceuticals Limited?
The ticker symbol for Telix Pharmaceuticals Limited is NASDAQ:TLX
Does Telix Pharmaceuticals Limited pay dividends?
No, Telix Pharmaceuticals Limited does not pay dividends
What sector is Telix Pharmaceuticals Limited in?
Telix Pharmaceuticals Limited is in the Healthcare sector
What industry is Telix Pharmaceuticals Limited in?
Telix Pharmaceuticals Limited is in the Biotechnology industry
What country is Telix Pharmaceuticals Limited based in?
Telix Pharmaceuticals Limited is headquartered in Australia
When did Telix Pharmaceuticals Limited go public?
Telix Pharmaceuticals Limited's initial public offering (IPO) was on 14 November 2024
Is Telix Pharmaceuticals Limited in the S&P 500?
No, Telix Pharmaceuticals Limited is not included in the S&P 500 index
Is Telix Pharmaceuticals Limited in the NASDAQ 100?
No, Telix Pharmaceuticals Limited is not included in the NASDAQ 100 index
Is Telix Pharmaceuticals Limited in the Dow Jones?
No, Telix Pharmaceuticals Limited is not included in the Dow Jones index
When does Telix Pharmaceuticals Limited report earnings?
The date for Telix Pharmaceuticals Limited's next earnings report has not been announced yet